OSUR OraSure Technologies, Inc.
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internatio…
Industry Peers
Medical Instruments & Supplies| Headline | Source | Time |
|---|---|---|
Older | ||
 OraSure (OSUR) Returns To Profit, But Growth Remains Elusive On August 5, OraSure Technologies (NASDAQ:OSUR) reported second-quarter 2026 results that included its first GAAP net income in years, a headline number of $6.2 million versus a $19.7 million loss a year earlier. Revenue of $30.6 million beat the company’s own guidance range and climbed 9.7% from the prior quarter. But look past the top […] | ||
 OraSure (OSUR) Q2 2026 Earnings Call Transcript Revenue beat guidance at $30.6M, but IntelliQ CT/NG FDA clearance delayed to 2027. | ||
 OraSure Technologies, Inc. Q2 2026 Earnings Call Summary Moby summary of OraSure Technologies, Inc.'s Q2 2026 earnings call | ||
OraSure Technologies Inc (OSUR) (Q2 2026) Earnings Call Highlights: Revenue Surges 9. ... OraSure exceeds Q2 guidance with strong growth in diagnostics and sample management, while navigating regulatory delays and maintaining a robust cash position. | ||
 OraSure Technologies Q2 Earnings Call Highlights OraSure Technologies (NASDAQ:OSUR) reported second-quarter revenue of $30.6 million, exceeding its guidance range and rising 9.7% sequentially, as stronger public-health diagnostics demand and growth in sample-management products supported results. President and Chief Executive Officer Carrie Eglin | ||